ELOS B — Elos Medtech AB Balance Sheet
0.000.00%
- SEK1.64bn
- SEK1.52bn
- SEK888.54m
- 82
- 28
- 21
- 37
Annual balance sheet for Elos Medtech AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 49 | 55.2 | 88.5 | 95.1 | 169 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 82.7 | 70.3 | 80.5 | 107 | 134 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 302 | 305 | 335 | 383 | 551 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 374 | 444 | 412 | 470 | 562 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 957 | 1,035 | 1,002 | 1,126 | 1,423 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 155 | 138 | 156 | 175 | 155 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 449 | 495 | 462 | 492 | 624 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 508 | 540 | 540 | 634 | 798 |
Total Liabilities & Shareholders' Equity | 957 | 1,035 | 1,002 | 1,126 | 1,423 |
Total Common Shares Outstanding |